EM Vision: Ledger

Stories naming EM Vision. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

Investor	Rounds	Invested
No investors recorded yet. Know one?

Company	Kind	Announced	Price	Sources
EM Vision is not recorded as having acquired anything.

Name	Role	Sources
John Keep	Chairman	sharecafe.com.au

Unnamed stage ~$8m

Strong Demand Fuels Ceretas IPO, Early ASX Debut Looms

UQ medtech spin-out Ceretas sold its IPO, raising about $8 million, and now targets a fast-tracked ASX debut; the article also recalls ResApp's 2022 acquisition by Pfizer.

sharecafe.com.au 14 Jul 2026 Ceretas Caravel Securities EM Vision Pfizer ResApp Taurus Capital University of Queensland Clem Jones Group John Keep Ryan Laws Tony Keating

Also kalkine.com.au·Dealroom

EM Vision

Funding history

Investors

What EM Vision bought

People

Coverage

Strong Demand Fuels Ceretas IPO, Early ASX Debut Looms